JOBS LOST IN FIRM'S U.S. MOVE

DAVID ELKS

12:00 - 02 July 2003

A Medical research company has shut down its South Cheshire headquarters, despite winning 900,000 of orders for technology to help fight the deadly Sars virus. An undisclosed number of staff at Crewe-based Osmetech have been made redundant after the company transferred its research operations to America.

The news comes as the company reported a boom in sales of a blood gas analyser to China over the past month to monitor patients with Severe Acute Respiratory Syndrome (Sars).
A spokesman for Osmetech, which employs 38 staff at the town's business park, said the decision followed a 2.2 million deal to take over pharmaceutical giant Roche's sensor division OPTI in March.
He said: "When they bought the company they also took on about 50 new staff involved in research and marketing.
"It was felt that Osmetech is still a fairly small company and having research operations split between the two sites was not efficient."

Following the move, the majority of research will now be conducted at OPTI's headquarters in Atlanta, while the company's registered headquarters has shifted to London.
This will enable the company to continue its listing on the London Stock Exchange's Alternative Investment Market. The executive directors will also be based in London.
The spokesman said that a number of workers in the North-West of England will remained involved in research while working from home.

The news comes as the company confirmed it had picked up 910,000 of orders for its equipment following the Sars virus outbreak in the Far East.
The handheld device cannot diagnose the virus, although it has optical sensors which can measure vital bodily conditions during treatment of its pneumonia-like symptoms. It measures blood gas, electrolyte and metabolite levels and can be used for measuring the oxygen saturation and acid-base balance in Sars patients.
Osmetech said this would be particularly useful in cases where treatment required the use of a ventilator for "supplemental oxygen" therapy.

The deal will help Osmetech, which is estimated by analysts Evolution Beeson Gregory to suffer losses of 3.2 million in the current financial year, push its way towards profitability. The orders received this month are already 10 times higher than the last financial year.

In January the company confirmed it had won approval from the U.S. Food and Drug Administration for its sensor, which uses electronics technology to 'sniff' out bacteria which can cause miscarriages - a market worth between 900 million and 1.2 billion in the U.S.

The group cut losses by 20 per cent to 533,000 in the six months to January and is due to report its annual figures on July 30.

david.elks@thesentinel.co.uk

cheers Pal

thanx....pal

Osmetech PLC
13 January 2004

Osmetech plc ('Osmetech')

Notification of Interim Results announcement

Osmetech, the developer of medical devices, is to announce its interim results
for the six months to 31st October 2003, on Thursday 29th January 2004.

Ends


This information is provided by RNS
The company news service from the London Stock Exchange

nice little rise again ... expect it continue northwards leading upto results and after as analysts predict the results vll be good .. i hold some .

OG.,
re- your no 31 post,please don`t ramp the stock,let price takes its own course! i am still only halfway to my " 1m shares" target. I don`t want paying
too much to accum. it!! 10-15p? its a joke. I am looking for @100p+ after 3-5 years!OF course AS an INVESTOR. rgds, SBR

SBR,

No ramp intended, just curious to see if there was any substance to the rumours though it appears as though it was just hot air.

I'm only in for 100K at present, though if they keep nudging up, I could be tempted to build a stake and turn investor.

Cheers

OG

where are those rampers......

There's normally plenty to be found on advfn!

i have heard the same.

OG, price of the com. shown gradually raise on a market-down day,just a little bit disappointed that volume is`nt match it. Will add more while price break
last summer`s high. rgds SBR.

SBR, most of my small caps. tend to rise on a market down day. I've been eyeing up OMH for a possible T-trade also, though I've not been convinced that the short-term rise would warrant it.

This could be good news for long-termers, if all T-traders are thinking like me then there won't be the same fall in price after the results - this should help to drive the price past last summer's high. I've got a feeling that the results are going to be good (OPTI is the key), we should see further rises from tomorrow onwards - all will be revealed soon.

OG

guys, actions accelerate now,SIT TIGHT!

Excuse my ignorance. What is a T-trade?

Marty Boy,

It's the an extended settlement time some brokers allow.

It's possible to trade at e.g. T+15 which means that you order a chunk of shares today but don't have to pay for them until 15 days later.

You'll be charged a bit more than the normal broker's commission for the privilege, however it makes it possible to order a load of shares before results are due (hoping that the price will be rising in anticipation) and then sell just before results thereby making a profit on shares you never paid for in the first place!

OG

OMH closed near top today, if it break 5p & close above that level,it has some good story to tell, next price level? may hit 7p very soon, DYOR!

og,
Re-Omh,if at 7-13 pence range ,is in the final stage of its recovery,i think once the share price break pass this level,say 13.25p ,that is suggustion of a new milestone--begins of the growth phase story.To me it can be a multi baggers then. rgds SBR.

what a battle! If bull won at today`s closing session, the price should rocket tomorrow, if not?! JUST WAIT..... :-))

what is cx and what does it mean for the company ?

windy,

Check out:

http://futures.tradingcharts.com/learning/technical_indicators.html

SBR - I'm waiting :-))